Get startedLog in
    Picture of ADC Therapeutics SA logo

    ADCT — ADC Therapeutics SA News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Adc Therapeutics SA Says Expected Cash Runway Extended Into Middle Of 2025

    Picture of ADC Therapeutics SA logoADC Therapeutics SA
    28/02/2023 14:53
    Feb 28 (Reuters) - ADC Therapeutics SA  ADCT.N :
    * EXPECTED CASH RUNWAY EXTENDED INTO MIDDLE OF 2025
    * ANTICIPATED DECREASE IN TOTAL OPERATING EXPENSES IN 2023
AND
2024 AS COMPARED TO 2022
    * EXPECTED TO GROW ZYNLONTA FY 2023 NET PRODUCT SALES BY A
DOUBLE-DIGIT PERCENTAGE YEAR-OVER-YEAR
    * QTRLY LOSS PER SHARE $0.30

Source text for Eikon:  ID:nBwc7vQ2ga 
Further company coverage:  ADCT.N

    Recent news on ADC Therapeutics SA

    See all news